These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8725717)
1. The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generation. Delorme MA; Tam AS; Xu L Thromb Haemost; 1996 May; 75(5):747-51. PubMed ID: 8725717 [TBL] [Abstract][Full Text] [Related]
2. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318 [TBL] [Abstract][Full Text] [Related]
5. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Andrew M; Mitchell L; Berry L; Paes B; Delorme M; Ofosu F; Burrows R; Khambalia B J Clin Invest; 1992 Jan; 89(1):321-6. PubMed ID: 1729278 [TBL] [Abstract][Full Text] [Related]
6. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Bendayan P; Boccalon H; Dupouy D; Boneu B Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383 [TBL] [Abstract][Full Text] [Related]
7. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents. Merton RE; Thomas DP Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248 [TBL] [Abstract][Full Text] [Related]
8. Activation of heparin cofactor II by heparin and dermatan sulfate. Tollefsen DM Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014 [TBL] [Abstract][Full Text] [Related]
9. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding. Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate. Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula. Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662 [TBL] [Abstract][Full Text] [Related]
12. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma. Dupouy D; Sié P; Dol F; Boneu B Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919 [TBL] [Abstract][Full Text] [Related]
13. [Dermatan sulfate and the prevention of experimental venous thrombosis]. Desnoyers P; Bara L; Samama M Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate. Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760 [TBL] [Abstract][Full Text] [Related]
15. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate. Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist. Buchanan MR; Brister SJ Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate. Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256 [TBL] [Abstract][Full Text] [Related]
19. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues. Osborne SA; Daniel RA; Desilva K; Seymour RB Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656 [TBL] [Abstract][Full Text] [Related]
20. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4. Tollefsen DM; Pestka CA J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]